Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7547
+0.0427 (6.00%)
At close: Feb 6, 2026, 4:00 PM EST
0.7460
-0.0087 (-1.15%)
After-hours: Feb 6, 2026, 7:59 PM EST
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,627,561
Market Cap
15.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 23 | 0 | - |
| Sep 30, 2024 | 23 | 1 | 4.55% |
| Sep 30, 2023 | 22 | 1 | 4.76% |
| Sep 30, 2022 | 21 | 6 | 40.00% |
| Sep 30, 2021 | 15 | 5 | 50.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Quantum BioPharma | 17 |
| FibroBiologics | 13 |
| Genenta Science | 13 |
| Iterum Therapeutics | 9 |
| Traws Pharma | 7 |
| Lexaria Bioscience | 7 |
| Pasithea Therapeutics | 4 |
CTXR News
- 6 weeks ago - Stock Market Today: Dow Jones, S&P 500 Futures Drop On Christmas Eve Despite Strong Q3 GDP Report—UiPath, AST SpaceMobile, Ramaco Resources In Focus - Benzinga
- 6 weeks ago - Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 2 months ago - Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 2 months ago - Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - PRNewsWire
- 2 months ago - Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) - PRNewsWire
- 2 months ago - Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting - PRNewsWire